Skip to main content

Table 3 Laboratory prepared mixture results of the current HPLC method for the determination of EMP, LIN, and MET along with MEL and CYG as MET potential official impurities

From: HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application

MIX

EMP

EMP Found

% Recovery a of EMP

LIN

LIN Found

% Recovery a of LIN

MET

MET Found

% Recovery a of MET

MEL

CYG

1

5.00

5.01

100.20

5.00

4.92

98.58

5.00

4.94

98.95

2.50

2.50

2b

5.00

5.01

100.20

1.00

1.01

101.01

200.00

203.17

101.58

10.00

10.00

3

2.50

2.53

101.21

0.50

0.49

98.94

100.00

100.45

100.45

20.00

20.00

4

4.00

3.96

99.07

3.00

2.96

98.76

10.00

9.86

98.61

4.00

4.00

5

7.00

6.90

98.59

6.00

6.03

100.58

20.00

20.01

100.05

5.00

5.00

 

Mean ± SD

99.83 ± 1.022

Mean ± SD

99.58 ± 1.131

Mean ± SD

99.93 ± 1.196

  
  1. a Mean of three determinations
  2. b Ratio present in tablet dosage form
  3. EMP, empagliflzin; LIN, linagliptin; MET, metformin